Biomaterials Science · 2021 · 41 citations · 19 references
Life SciencesImmunologyMolecular PharmaceuticsDrug DeliveryInnate ImmunityNanoparticle Drug DeliveryCell-nanoparticle InteractionsFibrosisHepatic FibrosisLiver DiseaseNanocarriers For TherapeuticsNanomedicineExosome-based TherapyFibrogenic CytokinesKupffer Cell FunctionKupffer Cell Mediated FibrogenesisKupffer Cell UptakeKupffer CellsLiver Fibrosis ProgressionNanoparticle-based Macrophage Targeting
-induced fibrosis mouse model by inhibiting the proliferation of fibroblasts. Furthermore, the inhibited Kupffer cells regenerated within 10 days after dosage withdrawal. Unlike carrier-free NIN treatment, CLD/NIN@LIEV induced a marked decrease in liver enzymes, indicating improved safety and anti-fibrosis efficacy. These results indicate its great potential for treatment with the combined anti-fibrosis agent and Kupffer cell inhibition strategies to enhance the liver fibrosis therapy.
19
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Ali A. Mokdad, Alan D López, Saied Shahraz et al. · BMC Medicine · 2014 · 1.1K citations · Full text